SeraCare Life Sciences, Inc.

133 articles about SeraCare Life Sciences, Inc.

• SeraCare Life Sciences Launches First-Ever Tumor Mutational Burden Reference Materials

  10/31/2019

  SeraCare Life Sciences, part of the LGC Clinical Diagnostics Business Unit and a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories, announced today the commercial release of the first ever genomic DNA (gDNA) and formalin-fixed paraffin-embedded (FFPE) reference materials for tumor mutational burden (TMB) measurement by next-generation sequencing (NGS) assays

• IQN Path Selects SeraCare Life Sciences for First-Ever Tumor Mutational Burden External Quality Assessment Program

  3/27/2019

  International expert group focused on improving quality of clinical biomarker testing launching pilot TMB proficiency program in Spring 2019

• LGC Acquires Seracare Life Sciences, Strengthening Its Position in Clinical Quality Control Tools

  11/26/2018

  Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories. 

• SeraCare Announces Exclusive Partnership with AccuRef Diagnostics

  10/29/2018

  SeraCare to offer AccuRef cancer reference materials alongside their Seraseq® portfolio of NGS cancer products

• 

  BioSpace Movers and Shakers Oct. 29

  10/29/2018

  Biopharma companies shore up leadership roles with new hires and appointments, at Axcella Health, Twist Bioscience, and more.

• SeraCare Announces Launch of Expanded NTRK Reference Material Panel

  10/22/2018

  An important new tool for labs seeking to detect NTRK gene fusions by next-generation sequencing

• SeraCare Announces the Expansion of Their Proprietary AccuPlex™ Technology Product Portfolio with the Launch of the AccuSpan™ HCV RNA Linearity Panel

  7/25/2018

  SeraCare Life Sciences is announcing the launch of their all-new AccuSpan™ HCV RNA Linearity Panel

• SeraCare Partners with NAVICAN on Implementation of Best-In-Class QC Workflow for TheraMap Precision Cancer Care™ Services

  4/17/2018

  Leading NGS QC Software is integrated into their Philips IntelliSpace Genomics Platform

• SeraCare Announces Industry's First CNV-Specific Reference Material for Gene Amplifications in Breast, Lung, and Brain Cancer

  2/14/2018

  These expert-designed products are built with innovative biosynthetic technology that is easily scalable to incorporate new CNVs over time.

• SeraCare Life Sciences Announces Joe Bernardo as New Company Chairman

  1/8/2018

  Mr. Bernardo is also an Operating Partner at Linden Capital Partners who are the equity investors behind SeraCare Life Sciences.

• SeraCare Announces Industry's First Comprehensive NGS Reference Material for Hematologic Malignancies

  11/8/2017

  To help clinical labs performing NGS-based myeloid testing thoroughly understand and characterize their assays, SeraCare has developed the Seraseq Myeloid Mutation DNA Mix and Seraseq Myeloid Fusion RNA Mix.

• SeraCare Life Sciences Announces The Launch Of A Suite Of Zika Virus Reference Materials For Improved Diagnostic Testing

  8/1/2017

• SeraCare Life Sciences Announces The Most Patient-Like cfDNA QC Technology

  7/18/2017

• SeraCare Life Sciences Announces QC Software Enhancements For Higher Confidence In NGS Assay Performance

  6/27/2017

• SeraCare Life Sciences Announces Launch Of Industry's First Multiplexed Inherited Cancer Reference Material

  3/24/2017

• SeraCare Life Sciences Announces New Highly Multiplexed Fusion RNA Assay Reference Standards

  2/21/2017

• SeraCare Life Sciences Launches Two New Seraseq Reference Materials For Clinical Oncology Assays

  11/14/2016

• SeraCare Life Sciences To Support Non-Invasive Prenatal Testing (NIPT) Proficiency Program In Collaboration With UK NEQAS

  11/10/2016

• SeraCare Life Sciences Collaborates With ArcherDX On RNA Fusion Reference Standards

  11/10/2016

• SeraCare Life Sciences Develops Industry's First Multiplexed Cardiomyopathy Reference Material

  10/20/2016